7α-Methyl-19-norandrostenedione

7α-Methyl-19-norandrostenedione.svg

7α-Methyl-19-norandrostenedione (MENT dione) is a synthetic androgen and anabolic steroid (AAS) which was never marketed. It is a derivative of nandrolone (19-nortestosterone) and is closely related to trestolone (7α-methyl-19-nortestosterone; MENT).

Chemical structure

7α-Methyl-19-norandrostenedione is a 19-norandrostane steroid and a derivative of nandrolone. It is specifically the 7α-methyl derivative of 19-norandrostenedione (nandrolone precursor). The chemical structure of 7α-Methyl-19-norandrostenedione is characterized by the presence of a methyl group at the 7α position and a ketone group at the 3 and 17 positions.

Pharmacology

As an androgen and anabolic steroid, 7α-Methyl-19-norandrostenedione is expected to have similar properties to other compounds in its class, such as promoting muscle growth and increasing male secondary sexual characteristics. However, due to the presence of the 7α-methyl group, it may have different pharmacokinetic properties and potency compared to other nandrolone derivatives.

Synthesis and metabolism

The synthesis of 7α-Methyl-19-norandrostenedione involves the chemical modification of nandrolone or its precursors. The metabolism of this compound in the body would likely involve reduction and oxidation reactions similar to other androgens and anabolic steroids, leading to the formation of various metabolites.

Potential uses

While 7α-Methyl-19-norandrostenedione was never marketed, compounds in this class are typically investigated for their potential use in hormone replacement therapy, treatment of muscle wasting conditions, and other medical applications where androgens and anabolic steroids are beneficial.

Legal status

The legal status of 7α-Methyl-19-norandrostenedione varies by country. In many jurisdictions, it may be classified as a controlled substance due to its potential for abuse and similarity to other anabolic steroids.

See also

• Nandrolone
• Trestolone
• Anabolic steroid
• Androgen